Compile Data Set for Download or QSAR
maximum 50k data
Found 36 Enz. Inhib. hit(s) with all data for entry = 50013319
TargetCathepsin K(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129070(Acetic acid (2S,3S)-3-((S)-2-benzyloxycarbonylamin...)
Affinity DataKi:  2.20nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129075(Acetic acid (2S,3S)-3-[(1-benzyloxycarbonylamino-c...)
Affinity DataKi:  5.70nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129071(Acetic acid (1S,2S,4R)-3-[(2-benzyloxycarbonylamin...)
Affinity DataKi:  8.80nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129070(Acetic acid (2S,3S)-3-((S)-2-benzyloxycarbonylamin...)
Affinity DataKi:  9.20nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin SMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129070(Acetic acid (2S,3S)-3-((S)-2-benzyloxycarbonylamin...)
Affinity DataKi:  88nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129071(Acetic acid (1S,2S,4R)-3-[(2-benzyloxycarbonylamin...)
Affinity DataKi:  130nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin SMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129077(Acetic acid (2S,3S)-3-[(1-benzyloxycarbonylamino-c...)
Affinity DataKi:  160nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129074(2-((2S,3S)-2-Acetoxy-4-oxo-azetidin-3-ylcarbamoyl)...)
Affinity DataKi:  200nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129073(CHEMBL64612 | [1-((3S,4S)-2-Oxo-4-phenoxy-azetidin...)
Affinity DataKi:  380nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129078(2-((2S,3S)-2-Acetoxy-4-oxo-azetidin-3-ylcarbamoyl)...)
Affinity DataKi:  950nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129075(Acetic acid (2S,3S)-3-[(1-benzyloxycarbonylamino-c...)
Affinity DataKi:  950nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin SMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin B(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129071(Acetic acid (1S,2S,4R)-3-[(2-benzyloxycarbonylamin...)
Affinity DataKi:  1.60E+3nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129076(Acetic acid (2S,3S)-3-{[(R)-2-((S)-benzyloxycarbon...)
Affinity DataKi:  2.10E+3nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin B(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129070(Acetic acid (2S,3S)-3-((S)-2-benzyloxycarbonylamin...)
Affinity DataKi:  2.10E+3nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129073(CHEMBL64612 | [1-((3S,4S)-2-Oxo-4-phenoxy-azetidin...)
Affinity DataKi:  3.40E+3nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin K(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129072(CHEMBL64245 | [1-((3S,4R)-2-Oxo-4-phenoxy-azetidin...)
Affinity DataKi:  3.60E+3nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin KMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129071(Acetic acid (1S,2S,4R)-3-[(2-benzyloxycarbonylamin...)
Affinity DataKi:  3.70E+3nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin B(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129075(Acetic acid (2S,3S)-3-[(1-benzyloxycarbonylamino-c...)
Affinity DataKi:  4.30E+3nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129075(Acetic acid (2S,3S)-3-[(1-benzyloxycarbonylamino-c...)
Affinity DataKi:  6.80E+3nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin B(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129077(Acetic acid (2S,3S)-3-[(1-benzyloxycarbonylamino-c...)
Affinity DataKi:  7.70E+3nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129076(Acetic acid (2S,3S)-3-{[(R)-2-((S)-benzyloxycarbon...)
Affinity DataKi:  1.10E+4nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin SMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129072(CHEMBL64245 | [1-((3S,4R)-2-Oxo-4-phenoxy-azetidin...)
Affinity DataKi:  1.60E+4nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129074(2-((2S,3S)-2-Acetoxy-4-oxo-azetidin-3-ylcarbamoyl)...)
Affinity DataKi:  2.00E+4nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin SMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129077(Acetic acid (2S,3S)-3-[(1-benzyloxycarbonylamino-c...)
Affinity DataKi:  2.80E+4nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin SMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129073(CHEMBL64612 | [1-((3S,4S)-2-Oxo-4-phenoxy-azetidin...)
Affinity DataKi:  3.30E+4nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin SMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin B(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129076(Acetic acid (2S,3S)-3-{[(R)-2-((S)-benzyloxycarbon...)
Affinity DataKi:  5.20E+4nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129072(CHEMBL64245 | [1-((3S,4R)-2-Oxo-4-phenoxy-azetidin...)
Affinity DataKi:  5.30E+4nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin SMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin B(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129074(2-((2S,3S)-2-Acetoxy-4-oxo-azetidin-3-ylcarbamoyl)...)
Affinity DataKi:  6.50E+4nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin B(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129078(2-((2S,3S)-2-Acetoxy-4-oxo-azetidin-3-ylcarbamoyl)...)
Affinity DataKi:  1.20E+5nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin B(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129073(CHEMBL64612 | [1-((3S,4S)-2-Oxo-4-phenoxy-azetidin...)
Affinity DataKi:  1.40E+5nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129077(Acetic acid (2S,3S)-3-[(1-benzyloxycarbonylamino-c...)
Affinity DataKi:  1.40E+5nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129076(Acetic acid (2S,3S)-3-{[(R)-2-((S)-benzyloxycarbon...)
Affinity DataKi: >1.50E+5nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129074(2-((2S,3S)-2-Acetoxy-4-oxo-azetidin-3-ylcarbamoyl)...)
Affinity DataKi: >1.50E+5nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin B(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129072(CHEMBL64245 | [1-((3S,4R)-2-Oxo-4-phenoxy-azetidin...)
Affinity DataKi: >1.50E+5nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129078(2-((2S,3S)-2-Acetoxy-4-oxo-azetidin-3-ylcarbamoyl)...)
Affinity DataKi: >1.50E+5nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin S(Homo sapiens (Human))
Ligand Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50129078(2-((2S,3S)-2-Acetoxy-4-oxo-azetidin-3-ylcarbamoyl)...)
Affinity DataKi: >1.50E+5nMAssay Description:Inhibitory activity of the compound was measured against Cathepsin SMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed